Regenerative Medicine News
Cellular Dynamics Announces Agreement with AstraZeneca on Use of iPSC-derived Human Cells in Drug Discovery Research
January 3, 2013 - (CDI) - "Cellular Dynamics International, Inc. (CDI) today announced a Center of Excellence agreement with AstraZeneca to accelerate the pace of drug discovery through the use of human induced pluripotent stem cell (iPSC) lines and tissue cells." Read Full Article
Posted on
9-Jan-13
by Toto, Brent
Tags:
Science and Industry News
Trackback Url
|
Link to this post
| Bookmark this post with:
